PLx Pharma Winddown Corp. Quarterly Share-based Payment Arrangement, Expense in USD from Q3 2016 to Q3 2022

Taxonomy & unit
us-gaap: USD
Description
Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
Summary
PLx Pharma Winddown Corp. quarterly/annual Share-based Payment Arrangement, Expense history and growth rate from Q3 2016 to Q3 2022.
  • PLx Pharma Winddown Corp. Share-based Payment Arrangement, Expense for the quarter ending September 30, 2022 was $1.1M, a 57.1% increase year-over-year.
  • PLx Pharma Winddown Corp. Share-based Payment Arrangement, Expense for the twelve months ending September 30, 2022 was $4.3M.
  • PLx Pharma Winddown Corp. annual Share-based Payment Arrangement, Expense for 2021 was $2.9M, a 123% increase from 2020.
  • PLx Pharma Winddown Corp. annual Share-based Payment Arrangement, Expense for 2020 was $1.3M, a 44.4% increase from 2019.
  • PLx Pharma Winddown Corp. annual Share-based Payment Arrangement, Expense for 2019 was $900K, a 6.96% increase from 2018.
Share-based Payment Arrangement, Expense, Trailing 12 Months (USD)
Share-based Payment Arrangement, Expense, Quarterly (USD)
Share-based Payment Arrangement, Expense, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2022 $4.3M $1.1M +$400K +57.1% Jul 1, 2022 Sep 30, 2022 10-Q 2022-11-10
Q2 2022 $3.9M $1.1M +$500K +83.3% Apr 1, 2022 Jun 30, 2022 10-Q 2022-08-12
Q1 2022 $3.4M $1.1M +$500K +83.3% Jan 1, 2022 Mar 31, 2022 10-Q 2022-05-13
Q4 2021 $2.9M $1M Oct 1, 2021 Dec 31, 2021 10-K 2022-03-11
Q3 2021 $700K Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-10
Q2 2021 $600K Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-12
Q1 2021 $600K +$327K +120% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-13
Q1 2020 $273K Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-14
Q3 2019 $261K +$13K +5.27% Jul 1, 2019 Sep 30, 2019 10-Q 2019-11-08
Q4 2018 $841K $76.3K -$215K -73.8% Oct 1, 2018 Dec 31, 2018 10-K 2020-03-13
Q3 2018 $1.06M $248K -$695K -73.7% Jul 1, 2018 Sep 30, 2018 10-Q 2019-11-08
Q2 2018 $1.75M $236K +$32.7K +16.1% Apr 1, 2018 Jun 30, 2018 10-Q 2018-08-10
Q1 2018 $1.72M $282K +$93.6K +49.8% Jan 1, 2018 Mar 31, 2018 10-Q 2018-05-11
Q4 2017 $1.62M $291K Oct 1, 2017 Dec 31, 2017 10-K 2019-03-08
Q3 2017 $942K +$371K +64.9% Jul 1, 2017 Sep 30, 2017 10-Q 2018-11-09
Q2 2017 $203K Apr 1, 2017 Jun 30, 2017 10-Q 2018-08-10
Q1 2017 $188K Jan 1, 2017 Mar 31, 2017 10-Q 2018-05-11
Q3 2016 $571K Jul 1, 2016 Sep 30, 2016 10-Q 2017-11-09
* An asterisk sign (*) next to the value indicates that the value is likely invalid.